Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 11, 2015, Pages

  Brown, Julie ^a   Martis, Ruth ^a   Hughes, Brenda ^b   Rowan, Janet ^c   Crowther, Caroline A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c National Women's Health   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ADIPONECTIN; CHLORPROPAMIDE; FATTY ACID; GLIBENCLAMIDE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; ORAL ANTIDIABETIC AGENT; TOLBUTAMIDE; TRIACYLGLYCEROL;

CESAREAN SECTION; CLINICAL OUTCOME; DRUG EFFICACY; FEMALE; FETAL WELL BEING; FETUS OUTCOME; HEALTH CARE UTILIZATION; HUMAN; HYPOGLYCEMIA; INFANT MORTALITY; LARGE FOR GESTATIONAL AGE; MATERNAL HYPERTENSION; MATERNAL WELFARE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERINATAL MORTALITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

EID: 84969494947     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011967     Document Type: Review

References (80)

1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Obstetrics & Gynecology 2013;122(2 Pt 1):406-16.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36(Suppl 1):567-74.
3. Anderberg E, Kallen K, Berntorp K. The impact of gestational diabetes mellitus on pregnancy outcome comparing different cut-off criteria for abnormal glucose tolerance. Acta Obstetricia et Gynecologica Scandinavica 2010;89(12):1532-7.
4. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007;30(Suppl 2):S111-S119.
5. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373(9677):1173-9.
6. Bottalico JN. Recurrent gestational diabetes: risk factors, diagnosis, management, and implications. Seminars in Perinatology 2007;31(3):176-84.
7. Boyadzhieva MV, Atanasova I, Zacharieva S, Tankova T, Dimitrova V. Comparative analysis of current diagnostic criteria for gestational diabetes mellitus. Obstetric Medicine 2012;5:71-7.
8. Brayfeld A (editor). Martindale: The Complete Drug Reference. London: Pharmaceutical Press, 2014.
9. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 2013;37 (Suppl 1):S1-S212.
10. Catalano PMA, Huston-Presley TL, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. American Journal of Obstetrics & Gynecology 2003;189(6):1698-704.
11. Chamberlain C, McNamara B, Williams E, Yore D, Oldenburg B, Oats J, et al. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States. Diabetes/Metabolism Research Reviews 2013;29(4):241-56.
12. Chasan-Taber L, Schmidt MD, Pekow P, Sternfeld B, Manson JE, Solomon CG, et al. Physical activity and gestational diabetes mellitus among Hispanic women. Journal of Women's Health 2008;17(6):999-1008.
13. Christesen H, Melender A. Prolonged elimination of tolbutamide in a premature newborn with hyperinsulinaemic hypoglycaemia. European Journal of Endocrinology 1998;138(6):698-701.
14. Clapp JF. Effects of diet and exercise on insulin resistance during pregnancy. Metabolic Syndrome and Related Disorders 2006;4(2):84-90.
15. Coustan DR, Lowe LP, Metzger BE, Dyer AR, International Association of Diabetes and Pregnancy Study Groups. The hyperglycemia and adverse pregnancy outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 2010;202(6):654.e1-654.e6.
16. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine 2005;352(24):2477-86.
17. Cundy T, Ackermann E, Ryan EA. Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 2014;348:g1567.
18. Cypryk K, Szymczak W, Czupryniak L, Sobczak M, Lewinski A. Gestational diabetes mellitus - an analysis of risk factors. Endokrynologia Polska (Warszawa) 2008;59(5):393-7.
19. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005;28(3):579-84.
20. Devlieger R, Casteels K, Van Assche FA. Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring. Acta Obstetricia et Gynecologica Scandinavica 2008;87(12):1266-70.
21. Duran A, Saenz S, Torrejon M, Bordiu E, del Valle L, Galindo M, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos gestational diabetes study. Diabetes Care 2014;37:2442-50.
22. Ekpebegh CO, Coetzee EJ, van der Merwe L, Levett NS. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabetic Medicine 2007;24(3):253-8.
23. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. American Journal of Obstetrics and Gynecology 1991;165(4 pt1):807-12.
24. Esakoff TF, Cheng YW, Sparks TN, Caughey AB. The association between birthweight 4000g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 2009;200(6):672.e1-672.e4.
25. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007;30(Suppl 2):S141-S146.
26. Fonte P, Araujo F, Reis S, Sarmento B. Oral insulin delivery: How far are we?. Journal of Diabetes Science and Technology 2013;7(2):520-31.
27. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertility and Sterility 2006;86(3):658-63.
28. Guerrero-Romero F, Aradillas-García C, Simental-Mendia LE, Monreal-Escalante E, de la Cruz Mendoza E, Rodríguez-Moran M. Birth weight, family history of diabetes, and metabolic syndrome in children and adolescents. Journal of Pediatrics 2010;156(5):719-23.
29. The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy Outcomes. New England Journal of Medicine 2008;358:1991-2002.
30. Harder T, Roepke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A. Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. American Journal of Epidemiology 2009;169(12):1428-36.
31. Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus. Obstetrics & Gynecology 2010;115(3):597-604.
32. Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstetricia et Gynecologica Scandinavica 2008;87(2):134-45.
33. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
34. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007;30(9):2287-92.
35. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. The Australasian Diabetes in Pregnancy Society. Gestational diabetes mellitus-management guidelines. Medical Journal of Australia 1998;169(2):93-7.
36. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676-82.
37. Iyer H, Khedkar A, Verma M. Oral insulin - a review of current status. Obesity and Metabolism 2010;12(3):179-85.
38. Jastrow N, Roberge S, Gauthier RJ, Laroche L, Duperron L, Brassard N, et al. Effect of birth weight on adverse obstetric outcomes in vaginal birth after cesarean delivery. Obstetrics & Gynecology 2010;115(2 Pt 1):338-43.
39. Ju H, Rumbold AR, Willson KJ, Crowther CA. Effect of birth weight on adverse obstetric outcomes in vaginal birth after caesarean delivery. BMC Pregnancy and Childbirth 2008;8:31.
40. Kalra B, Gupta Y, Singla R, Klara S. Use of oral anti-diabetic agents in pregnancy: A pragmatic approach. North American Journal of Medicine & Science 2015;7(1):6-12.
41. Kemball ML, McIver C, Milner RDG, Nourse CH, Schiff D, Tiernan JR. Neonatal hypoglycaemia in infants of diabetic mothers given sulphonyureas drugs in pregnancy. Archives of Disease in Childhood 1970;45(243):696-701.
42. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-8.
43. Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes attributable to overweight and obesity. American Journal of Public Health 2010;100(6):1047-52.
44. Knopp RH, Bergelin RO, Wahl PW, Walden CE. Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes 1985;34(Suppl2):71-7.
45. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clinical Obstetrics and Gynecology 2007;50(4):938-48.
46. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine 2009;361(14):1339-48.
47. Langer O, Conway D, Berkus M, Xenakis E-J, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. New England Journal of Medicine 2000;343(16):1134-8.
48. Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. American Journal of Obstetrics and Gynecology 2005;192(4):989-97.
49. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21(Suppl 2):B161-B167.
50. Metzger B, for The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine 2008;358:1991-2002.
51. Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington: Ministry of Health, 2014.
52. Morisset AS, St-Yves A, Veillette J, Weisnagel SJ, Tchernof A, Robitaille J. Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes/Metabolism Research and Reviews 2010;26(1):17-25.
53. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years late. Journal of Pediatrics 2008;152(2):201-6.
54. Mulla WR, Henry TQ, Homko CJ. Gestational diabetes screening after HAPO: has anything changed?. Current Diabetes Reports 2010;10(3):224-8.
55. Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, et al. ADIPS consensus guidelines for the testing and diagnosis of hyperglycaemia in pregnancy in Australia and New Zealand. http://adips.org/downloads/2014ADIPSGDMGuidelinesV18.11.2014_000.pdf (accessed 2014).
56. National Institute for Health and Clinical Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-conception to the Postnatal Period. NICE clinical guideline 63. London: NICE, 2008.
57. National Institute for Health and Clinical Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-conception to the Postnatal Period. NICE clinical guideline NG3. London: NICE, 2015.
58. Ogunyemi DA, Fong A, Rad S, Kjos SL. Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Study group (IADPSG). Diabetes Medicine 2011;28(8):976-86.
59. Patane G, Piro S, Anello M, Rabuazzo, Vigneri R, Purrello F. Exposure to glibenclamide increases rat beta cells sensitivity to glucose. British Journal of Pharmacology 2000;129:887-92.
60. Petry CJ. Gestational diabetes: risk factors and recent advances in its genetics and treatment. British Journal of Nutrition 2010;104(6):775-87.
61. Petitt DJ, Bennett PH, Knowler WC, Baird HR, Aleck KA. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy. Long-term effects on obesity and glucose tolerance in the offspring. Diabetes 1985;34(Suppl 2):119-22.
62. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993;16(1):310-4.
63. Radó JP, Borbély L, Szende L, Fischer J, Takó J. Investigation of the diuretic effect of glibenclamide in healthy subjects and in patients with pituitary and nephrogenic diabetes insipidus. Hormone and Metabolic Research 1974;6(4):289-92.
64. Ragnarsdottir LH, Conroy S. Development of macrosomia resulting from gestational diabetes mellitus: physiology and social determinants of health. Advances in Neonatal Care 2010;10(1):7-12.
65. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373(9677):1789-97.
66. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
67. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, for the MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. New England Journal of Medicine 2008;358(19):2003-15.
68. Ryu RJ, Hays KE, Hebert MF. Gestational diabetes mellitus management with oral hypoglycemic agents. Seminars in Perinatology 2014;38(8):508-15.
69. Scwarz R, Rosenn B, Aleksa K, Koren G. Transplacental transfer of glyburide; is it clinically significant?. American Journal of Obstetrics and Gynecology 2013;208(Suppl 1):S25.
70. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008;31(8):1668-9.
71. Simmons D. Safety considerations with pharmacological treatment of gestational diabetes mellitus. Drug Safety 2015;38(1):65-78. [DOI: 10.1007/s40264-014-0253-9].
72. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278(13):1078-83.
73. Suman Rao PN, Shashidhar A, Ashok C. In utero fuel homeostasis: Lessons for a clinician. Indian Journal of Endocrinology and Metabolism 2013;17(1):60-8.
74. Tran TS, Hirst JE, Do MA, Morris JM, Jeffrey HE. Early prediction of gestational diabetes mellitus in Vietnam: clinical impact of currently recommended diagnostic criteria. Diabetes Care 2013;36(3):618-24.
75. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome?. Journal of Maternal-Fetal Medicine 2008;21(3):149-57.
76. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008;300(24):2886-97.
77. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1. Geneva, Switzerland: WHO, 1999.
78. World Health Organization. WHO Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. Report WHO/NMH/MND/13.2. Geneva, Switzerland: WHO, 2014.
79. Zhang C, Liu S, Solomon CG, Hu FB. Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care 2006;29(10):2223-30.
80. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2].